Intelligent Investor

Living Cell Technologies Limited (ASX: LCT) - Announcements

- Current share price for LCT : $0.014

ASX company news and announcements for Living Cell Technologies Limited (LCT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Living Cell Technologies Limited (LCT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Living Cell Technologies Limited (LCT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Living Cell Technologies Limited (LCT)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$23 Cleansing Statement 8 Sep 2023 3:58PM $0.014 $0.014 $0.015 fallen by 0%
$23 Application for quotation of securities - LCT 8 Sep 2023 3:56PM $0.014 $0.014 $0.015 fallen by 0%
$23 Company name and stock code change 8 Sep 2023 11:01AM $0.014 $0.014 $0.015 fallen by 0%
$23 LCT Global Announces Staffing Adjustment for NTCELL Project 5 Sep 2023 3:33PM $0.015 $0.014 $0.015 fallen by 6.67%
$23 Results of Meeting 1 Sep 2023 1:18PM $0.015 $0.014 $0.015 fallen by 6.67%
$23 LCT commences AI-116 pre clinical studies 1 Sep 2023 8:07AM $0.015 $0.014 $0.015 fallen by 6.67%
$23 Annual Report and Appendix 4E 30 Aug 2023 5:54PM $0.014 $0.014 $0.015 fallen by 0%
$23 Cleansing Statement 22 Aug 2023 3:38PM $0.014 $0.014 $0.015 fallen by 0%
$23 Application for quotation of securities - LCT 22 Aug 2023 3:36PM $0.014 $0.014 $0.015 fallen by 0%
$23 Notice of General Meeting/Proxy Form 28 Jul 2023 3:44PM $0.016 $0.014 $0.015 fallen by 12.50%
$23 Quarterly Activities/Appendix 4C Cash Flow Report 28 Jul 2023 8:14AM $0.017 $0.014 $0.015 fallen by 17.65%
$23 Patent application over AI-116 for Dementia filed 26 Jul 2023 8:29AM $0.016 $0.014 $0.015 fallen by 12.50%
$23 Name and Branding Change 11 Jul 2023 9:02AM $0.016 $0.014 $0.015 fallen by 12.50%
$23 Notification regarding unquoted securities - LCT 11 Jul 2023 8:16AM $0.016 $0.014 $0.015 fallen by 12.50%
$23 Application for quotation of securities - LCT 11 Jul 2023 8:16AM $0.016 $0.014 $0.015 fallen by 12.50%
$23 Application for quotation of securities - LCT 11 Jul 2023 8:15AM $0.016 $0.014 $0.015 fallen by 12.50%
$23 Proposed issue of securities - LCT 7 Jul 2023 3:32PM $0.016 $0.014 $0.015 fallen by 12.50%
$23 Proposed issue of securities - LCT 7 Jul 2023 3:30PM $0.016 $0.014 $0.015 fallen by 12.50%
$23 Initial Director's Interest Notice 5 Jul 2023 3:31PM $0.016 $0.014 $0.015 fallen by 12.50%
$23 Final Director's Interest Notice 5 Jul 2023 3:30PM $0.016 $0.014 $0.015 fallen by 12.50%
$23 Board Changes 3 Jul 2023 8:31AM $0.015 $0.014 $0.015 fallen by 6.67%
$23 Notice of initial substantial holder 22 Jun 2023 8:15AM $0.014 $0.014 $0.015 fallen by 0%
$23 NTCELL Project Update 19 Jun 2023 9:35AM $0.012 $0.014 $0.015 risen by 16.67%
$23 Appointment of Chief Scientific Officer 9 Jun 2023 8:52AM $0.011 $0.014 $0.015 risen by 27.27%
$23 CLEANSING STATEMENT 4 May 2023 2:08PM $0.009 $0.014 $0.015 risen by 55.56%

1 - 25 of 584 results

Page 1 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.